DOCK2 p.Ser217Ter
c.650C>A · rs755691445 · VCV2828268
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function in a LoF-intolerant gene |
|---|---|---|
| NMD | predicted | premature termination codon in exon 8 of 52 |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 5.9 | GERP 1.8, phastCons 1 |
| Overall | ||
| CADD | 38.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DOCK2
- Protein
- p.Ser217Ter
- Coding
- c.650C>A
- MANE Select
- NM_004946
- dbSNP
- rs755691445
- Type
- single nucleotide variant
- Location
- chr5:169684239 (GRCh38)
- Gene constraint
- LOEUF 0.421 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 80.40 · 6 PDB
Disease context
DOCK2 deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Combined immunodeficiency due to DOCK2 deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- DOCK2 p.Ser217Leu Uncertain significance ★★ ⚠ same residue
- INSYN2B p.Arg217Gly Uncertain significance ★ ⚠ same residue
- INSYN2B p.Arg217Thr Uncertain significance ★ ⚠ same residue
- DOCK2 c.2267+3G>A Uncertain significance ★★ same condition
- DOCK2 c.2704-3C>T Uncertain significance ★★ same condition
- DOCK2 c.4467+4A>G Uncertain significance ★★ same condition
- DOCK2 p.Ala1393Val Uncertain significance ★★ ⚠ same condition
- DOCK2 p.Ala1710Val Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dock2-p-ser217ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown